May 11, 2017 / 8:41 PM / 2 months ago

BRIEF-Akari Therapeutics says CEO Gur Roshwalb has been placed on administrative leave

1 Min Read

May 11 (Reuters) - Akari Therapeutics Plc

* Akari Therapeutics says Gur Roshwalb, CEO, has been placed on administrative leave - sec filing

* Akari Therapeutics says Ray Prudo in his role as executive chairman is temporarily assuming Roshwalb’S duties in his absence

* Akari Therapeutics - board has established ad hoc special committee to review involvement, if any, of co personnel with Edison investment research report Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below